[在预防和治疗糖尿病脚部时,功能内的应用进展]
Heng-Yu Liu1, Zhen-de Jiang1, Yao-Kuan Ruan1
1Department of Foot and Ankle Surgery, the Second Hospital of Jilin University, Changchun 130041, Jilin, China.
概括
功能性内为糖尿病脚 (DF) 并发症提供了一个非侵入性的解决方案. 材料,设计和制造方面的创新正在加强压力降低和个性化,用于DF预防和治疗.
科学领域:
- 足部医学是一门专业.
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
背景情况:
- 糖尿病脚 (DF) 影响全球15-25%的糖尿病患者.
- 对侧面的高风险 (50%在5年内) 需要有效的预防.
- 功能性内是DF管理的一个关键的非侵入性干预.
研究的目的:
- 审查用于预防和治疗糖尿病足的功能内的进展.
- 突出材料,结构设计,制造和智能监控方面的创新.
- 确定当前的研究热点和功能内开发的未来方向.
主要方法:
- 对材料创新的审查 (复合材料,智能材料).
- 结构优化的分析 (多层,局部减压).
- 检查制造工艺 (3D打印,参数设计) 和智能监控 (传感器).
主要成果:
- 新材料提高了减压和舒适度.
- 优化的结构允许精确调节压力.
- 3D打印使个性化内具有集成的监控功能.
- 临床研究证实,通过个性化内,发病率降低,愈合时间更快.
结论:
- 通过材料科学,结构工程和智能系统,功能性内正在进步.
- 个性化,智能化和标准化对于未来的DF预防和治疗解决方案至关重要.
- 在生物力学,标准化评估和长期疗效方面需要进一步的研究.
相关概念视频
Peripheral Artery Disease IV: Nursing Management
349
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
349
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
358
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
358
Peripheral Artery Disease III: Interprofessional Care
242
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
242
Peripheral Artery Disease I: Introduction
313
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
313
Peripheral Artery Disease V: Postoperative Nursing Management
376
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
376
Diabetes: Management and Pharmacotherapy
867
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
867


